Haneya Assad, Lanmüller Pia, Panholzer Bernd, Sommer Wiebke, Kuliczkowski Wiktor, Sokolski Mateusz, Przybylski Roman, Schmack Bastian, Ali-Hasan-Al-Saegh Sadeq, Takemoto Sho, Zayat Rachad, Werner Nikos
Department of Cardiothoracic Surgery, Heart Centre Trier, Barmherzigen Brueder Hospital, Nordallee 1, Trier 54292, Germany.
Department of Cardiothoracic and Vascular Surgery, Deutsches Herzzentrum der Charité, Augustenburger Platz 1, Berlin 13353, Germany.
Eur Heart J Suppl. 2025 Apr 28;27(Suppl 4):iv55-iv61. doi: 10.1093/eurheartjsupp/suaf003. eCollection 2025 Apr.
Heart transplantation (HTx) is a definitive treatment for selected patients with advanced heart failure. However, primary graft dysfunction (PGD), a severe early complication, is a major cause of post-HTx morbidity and mortality. This paper explores the pathophysiology, diagnostic approaches, and management strategies for PGD, with a particular focus on temporary mechanical circulatory support (MCS) devices such as venoarterial extracorporeal membrane oxygenation and Impella. It also highlights the essential role of the multidisciplinary Heart Team in optimizing outcomes through patient-tailored MCS selection and timely intervention.
心脏移植(HTx)是针对特定晚期心力衰竭患者的一种确定性治疗方法。然而,原发性移植功能障碍(PGD)作为一种严重的早期并发症,是心脏移植术后发病和死亡的主要原因。本文探讨了PGD的病理生理学、诊断方法和管理策略,特别关注临时性机械循环支持(MCS)设备,如静脉-动脉体外膜肺氧合和Impella。本文还强调了多学科心脏团队在通过为患者量身定制MCS选择和及时干预来优化治疗结果方面的重要作用。